Skip to main content
. 2020 Jun 11;5(1):e10. doi: 10.1017/cts.2020.494

Table 1.

Cycle threshold for values of five primer sets for each experimental condition. RNase P is used as an indicator in clinical specimens that sufficient human cellular material was collected, as well as an extraction/procedural control, and was included as reference. RNase P was likely present on N95 masks from skin contact during handling

Sample E-gene (Ct) N-gene (Ct) CDC N1 (Ct) CDC N2 (Ct) CDC N3 (Ct) RNase P (Extraction
Control) (Ct)
SARS-CoV-2 initial RNA
REF 20.67 26.67 19.1 18.45 19.33 32.1
ETOH 1860 26.23 32.63 25 28.1 26.1 33.2
ETOH 1870+ 30.33 37.01 28.4 33.1 30.4 33.5
ETOH 8511 26.9 32.62 25.2 28.5 26.5 33.3
+ Cntrl 1860 21.16 27.28 19.5 19.9 19.7 31.3
+ Cntrl1870+ 21.43 27.19 19.4 19.9 19.6 30.9
+ Cntrl 8511 20.76 26.72 19 19.4 19.4 32.5
UV 1860 20.95 27.14 19.2 19.9 19.8 33.2
UV Cntrl 1870+ 23.54 29.78 21.2 22.1 21.6 34.7
UV Cntrl 8511 21 27.3 19.3 19.9 19.5 34.3
VHP 1860 21.93 28.57 20.2 20.6 20.6 32.8
VHP 1870+ 22.13 28.68 20.4 21 20.8 31.6
VHP 8511 20.66 27.01 19 19.5 19.3 31.5
- Cntrl Undetected Undetected Undetected Undetected Undetected 36.1
SARS-CoV-2 cell culture infectivity RNA
REF 11.85 15.96 10.7 11 11.1 32.9
ETOH 1860 Undetected Undetected Undetected Undetected Undetected 43.3
ETOH 1870+ Undetected Undetected Undetected Undetected Undetected 41.7
ETOH 8511 Undetected Undetected Undetected Undetected Undetected 40.1
+ Cntrl 1860 11.96 15.72 10.8 11.1 11.2 34.4
+ Cntrl 1870 11.87 15.8 10.7 11.1 11.2 34.3
+ Cntrl 8511 12.02 16.32 10.9 11.2 11.3 35
UV 1860 11.76 15.83 10.6 11 11.1 35.7
UV Cntrl 1870+ 28.73 34.04 25.1 26.6 26.8 38.6
UV Cntrl 8511 11.83 15.88 10.7 11.1 11 33.6
VHP 1860 27.33 33.22 24.6 26.2 26.1 39
VHP 1870+ 28.79 33.23 25.3 25.9 25.9 38.3
VHP 8511 11.66 15.75 10.7 11.1 11.1 33.6
- Cntrl Undetected Undetected 36.5 35.1 Undetected 34.5